Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yein Jeon

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The Lancet. Global Health|March 16, 2023
Is dropping trial-of-antibiotic treatment in people with suspected tuberculosis enough?Thomas Nyirenda, Yein Jeon
Annals of Internal Medicine|February 13, 2023
Prevalence and Management of Obesity in U.S. Adults With Type 1 DiabetesMichael Fang, Yein Jeon, Justin B Echouffo-Tcheugui, et al.
Diabetes Research and Clinical Practice|June 15, 2023
Diabetic foot disease and the risk of major clinical outcomesMichael Fang, Jiaqi Hu, Yein Jeon, et al.
Journal of the American Geriatrics Society|April 1, 2026
Burden and Risk Factors of CGM-Detected Hypoglycemia in Older Adults With Type 2 DiabetesMichael Fang, Natalie Rula Daya, Yein Jeon, et al.
Transplantation and Cellular Therapy|November 8, 2025
A Practical Guide to Competing Risk Analysis for Transplant and Cell Therapy ResearchHéctor A Vaquera-Alfaro, Yein Jeon, Qian Vicky Wu, et al.
American Journal of Preventive Cardiology|August 10, 2023
Racial and ethnic differences in circulating N-terminal pro-brain-type natriuretic peptide (NT-proBNP) in US adultsYvonne Commodore-Mensah, Dan Wang, Yein Jeon, et al.
Haematologica|June 19, 2025
Extramedullary disease is associated with severe toxicities following B-cell maturation antigen CAR T-cell therapy in multiple myelomaAndrew J Portuguese, Emily C Liang, Jennifer J Huang, et al.
JCO Clinical Cancer Informatics|January 14, 2026
Time-Series Clustering Captures Patterns of Early Immune Effector Cell-Associated Hematotoxicity That Are Predictable Using Tree-Based ModelsEmily C Liang, Yein Jeon, Yang Qiao, et al.
Haematologica|July 2, 2026
A novel dose-dense strategy for CD19-directed CAR T-cell therapy is associated with durable responses without increased toxicity in patients with B-cell non-Hodgkin lymphomaValentín Ortiz-Maldonado, Emily C Liang, Jennifer J Huang, et al.
Haematologica|March 13, 2025
Real-world comparison of lisocabtagene maraleucel and axicabtagene ciloleucel in large B-cell lymphoma: an inverse probability of treatment weighting analysis with 3-year follow upAndrew J Portuguese, Jennifer J Huang, Yein Jeon, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Lancet. Global Health|March 16, 2023
Is dropping trial-of-antibiotic treatment in people with suspected tuberculosis enough?Thomas Nyirenda, Yein Jeon
Annals of Internal Medicine|February 13, 2023
Prevalence and Management of Obesity in U.S. Adults With Type 1 DiabetesMichael Fang, Yein Jeon, Justin B Echouffo-Tcheugui, et al.
Diabetes Research and Clinical Practice|June 15, 2023
Diabetic foot disease and the risk of major clinical outcomesMichael Fang, Jiaqi Hu, Yein Jeon, et al.
Journal of the American Geriatrics Society|April 1, 2026
Burden and Risk Factors of CGM-Detected Hypoglycemia in Older Adults With Type 2 DiabetesMichael Fang, Natalie Rula Daya, Yein Jeon, et al.
Transplantation and Cellular Therapy|November 8, 2025
A Practical Guide to Competing Risk Analysis for Transplant and Cell Therapy ResearchHéctor A Vaquera-Alfaro, Yein Jeon, Qian Vicky Wu, et al.
American Journal of Preventive Cardiology|August 10, 2023
Racial and ethnic differences in circulating N-terminal pro-brain-type natriuretic peptide (NT-proBNP) in US adultsYvonne Commodore-Mensah, Dan Wang, Yein Jeon, et al.
Haematologica|June 19, 2025
Extramedullary disease is associated with severe toxicities following B-cell maturation antigen CAR T-cell therapy in multiple myelomaAndrew J Portuguese, Emily C Liang, Jennifer J Huang, et al.
JCO Clinical Cancer Informatics|January 14, 2026
Time-Series Clustering Captures Patterns of Early Immune Effector Cell-Associated Hematotoxicity That Are Predictable Using Tree-Based ModelsEmily C Liang, Yein Jeon, Yang Qiao, et al.
Haematologica|July 2, 2026
A novel dose-dense strategy for CD19-directed CAR T-cell therapy is associated with durable responses without increased toxicity in patients with B-cell non-Hodgkin lymphomaValentín Ortiz-Maldonado, Emily C Liang, Jennifer J Huang, et al.
Haematologica|March 13, 2025
Real-world comparison of lisocabtagene maraleucel and axicabtagene ciloleucel in large B-cell lymphoma: an inverse probability of treatment weighting analysis with 3-year follow upAndrew J Portuguese, Jennifer J Huang, Yein Jeon, et al.
Pageof 2